
Technological creativity
In vitro diagnostics specialists today have to design systems capable of carrying out increasingly complex tests while making the results easier to interpret. HORIBA Medical has risen to the challenge by considerably intensifying its research efforts. The company aims to invest over 10% of its sales in R&D in the medium term.
Many new concepts, that are unique, have been introduced in the field of in vitro diagnostics, including the most compact system on the market (Micros designed by HORIBA Medical).
Over 40 “key” patent families have been lodged worldwide, covering all the technologies included in our testing systems.
14 Dec 2020 - New Oxford AHSN study demonstrates how primary care point-of-care testing can avoid unnecessary...
9 Oct 2020 - Award winning partnership between Britannia Pharmaceuticals, HORIBA Medical and Northumberland Tyne...
1 Aug 2020 - QSP 2.0: An Affordable Digital tool for “Skills Evaluation & Training” in blood morphology